REHAB Fontan Failure: A Trial of Cardiac Rehabilitation

Trial ID or NCT#

NCT06150950

Status

recruiting iconRECRUITING

Purpose

The goal of this clinical trial is to compare the impact of cardiac rehabilitation on Fontan failure patients' exertional tolerance, frailty, and quality of life. 1. Among patients with Fontan failure, will cardiac rehabilitation increase average daily steps compared to usual care? 2. Among patients with Fontan failure, will cardiac rehabilitation improve exertional tolerance (as measured by cardiopulmonary exercise testing), frailty, and self-reported quality of life metrics compared to usual care?

Official Title

RCT of the Effects of Cardiac reHABilitation (REHAB) Among Patients With Fontan Failure

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

Investigator(s)

Daniel Clark, MD, MPH
Daniel Clark, MD, MPH
Cardiologist, Adult congenital heart disease cardiologist, Obstetrics cardiologist
Clinical Associate Professor, Medicine - Cardiovascular Medicine Clinical Assistant Professor, Pediatrics - Cardiology

Contact us to find out if this trial is right for you.

Contact

DANIEL CLARK, MD, MPH
650-724-9220